Physician profile

Patrick W Kuhns

General Practice (Dentist) · Hagerstown, MD

NPI 1073007720

$2,257.70

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$791.26
Entertainment$128.86

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Straumann USA LLC $1,167.09 2020-2024
Zimmer Biomet Holdings, INC. $499.74 2019-2020
Zimvie INC. $447.62 2022-2024
Biohorizons Implant Systems INC. $88.45 2020-2023 Biohorizons
3m Company $19.83 2020
Philips North America LLC $12.04 2021
Ultradent Products INC $11.66 2021
Align Technology, INC. $11.27 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Patrick W Kuhns

$2,257.70

in general payments reported 2019-2025

Years
2019-2024
Top company
Straumann USA LLC

https://glasscript.com/doctor/5325473/patrick-w-kuhns

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.